2018-09-13T06:34:28-05:00 2017-12-31 231406493 MORISON COGEN LLP 484 NORRISTOWN RD STE 100 BLUE BELL PA 19422 990 2017-01-01 232818395 NATIONAL COMPREHENSIVE CANCER NETWORK NATI 2156900300 275 COMMERCE DRIVE NO 300 FORT WASHINGTON PA 19034 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 2156900300 2018-09-06 1 JOSEPH M KISTNER CPA P00157086 2674403000 100.11.134.178 2018-09-06 11:21:00 ED P B16AE35949C793F21FFF35EFABE8220B482A349A F061244EAF8291A5AD75BBECB28DE81C43B57F33 2017 2018-06-14 16:35:46Z ROBERT W CARLSON MD 275 COMMERCE DRIVE NO 300 FORT WASHINGTON PA 19034 34690999 0 X WWW.NCCN.ORG X 1993 DE TO IMPROVE THE QUALITY, EFFECTIVENESS, AND EFFICIENCY OF CANCER CARE SO THAT PATIENTS CAN LIVE BETTER LIVES. 27 27 126 1355 191214 85428 17007659 17844586 14874840 15819880 55545 147091 759259 879442 32697303 34690999 2532934 1774075 0 0 13867479 15518284 0 0 606467 9485274 9571673 25885687 26864032 6811616 7826967 49146910 56114451 17905985 17046656 31240925 39067795 X TO IMPROVE THE QUALITY, EFFECTIVENESS, AND EFFICIENCY OF CANCER CARE SO THAT PATIENTS CAN LIVE BETTER LIVES. 0 0 14053830 14609162 WITH EXPERTS FROM MAJOR ACADEMIC CANCER CENTERS, DEVELOP AND UPDATE CLINICAL PRACTICE GUIDELINES FOR TREATMENT OF CANCER; INCLUDES BOTH DISTRIBUTION OF GUIDELINES FOR NON-COMMERCIAL USE AS WELL AS CERTAIN EDUCATIONAL CONFERENCES AND SYMPOSIA TO COMMUNICATE CONTENT FREE OF CHARGE. 3083048 1334427 DISSEMINATION OF PATIENT INFORMATION BASED ON GUIDELINES; DEVELOPMENT AND DISSEMINATION OF MEASURES TO ACCESS THE QUALITY OF CARE. 2995987 1774075 DEVELOPMENT OF A CLINICAL RESEARCH NETWORK OF PHYSICIANS AT MEMBER ACADEMIC CANCER CENTERS TO FACILITATE THE CONDUCT OF STUDIES TO ADVANCE THE STATE-OF-THE-ART IN CANCER CARE. 2425147 755733 DEVELOPMENT OF OTHER PUBLIC AND PROFESSIONAL INFORMATION PROGRAMS TO FACILITATE ACCESS TO CANCER SPECIALTY SERVICES. 2425147 755733 22558012 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 236 0 1 126 1 1 1 0 0 0 0 0 0 0 0 0 X 27 27 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY LA ME MD MA MI MS MN MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X ROBERT W CARLSON MD 2156900300 275 COMMERCE DRIVE SUITE 300 FORT WASHINGTON PA 19034 JAN C BUCKNER MD DIRECTOR, VICE CHAIR 2.00 X 0 0 0 TIMOTHY J EBERLEIN MD DIRECTOR, CHAIR 2.00 X 0 0 0 LORI C PICKENS MHA DIRECTOR, SECRETARY 2.00 X 0 0 0 DOROTHY E PUHY MBA DIRECTOR, TREASURER 2.00 X 0 0 0 MATT KALAYCIO MD DIRECTOR 2.00 X 0 0 0 MARWAN G FAKIH MD DIRECTOR 2.00 X 0 0 0 THOMAS A D'AMICO MD DIRECTOR 2.00 X 0 0 0 RICHARD I FISHER MD DIRECTOR 2.00 X 0 0 0 KENNETH H COWAN MD PHD DIRECTOR 2.00 X 0 0 0 F MARC STEWART MD DIRECTOR 2.00 X 0 0 0 JOHN W SWEETENHAM MD FACP FRCP DIRECTOR 2.00 X 0 0 0 DAVID G PFISTER MD DIRECTOR 2.00 X 0 0 0 LOUIS B HARRISON MD DIRECTOR 2.00 X 0 0 0 AL B BENSON III MD FACP FASCO DIRECTOR 2.00 X 0 0 0 STEPHEN B EDGE MD FACS FASCO DIRECTOR 2.00 X 0 0 0 ALBERTO S PAPPO MD DIRECTOR 2.00 X 0 0 0 EBEN ROSENTHAL MD DIRECTOR 2.00 X 0 0 0 WILLIAM E CARSON III MD DIRECTOR 2.00 X 0 0 0 DAVID S ETTINGER MD FACP FCCP DIRECTOR 2.00 X 0 0 0 RANDAL S WEBER MD DIRECTOR 2.00 X 0 0 0 BARBARA PARKER MD DIRECTOR 2.00 X 0 0 0 ALAN P VENOOK MD DIRECTOR 2.00 X 0 0 0 LISLE M NABELL MD DIRECTOR 2.00 X 0 0 0 W THOMAS PURCELL MD MBA DIRECTOR 2.00 X 0 0 0 SAMUEL M SILVER MD PHD MACP DIRECTOR 2.00 X 0 0 0 RUTH M O'REGAN MD DIRECTOR 2.00 X 0 0 0 MICHAEL N NEUSS MD DIRECTOR 2.00 X 0 0 0 ROGERIO LILENBAUM MD DIRECTOR 2.00 X 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 40.00 X 802012 0 64210 GARY WEYHMULLER CHIEF OPERATING OFFICER 40.00 X 432213 0 70210 LISA G KIMBRO CHIEF FINANCIAL OFFICER 40.00 X 320940 0 68201 JOAN S MCCLURE SENIOR VP, CLINICAL INFORM 40.00 X 320106 0 56843 C LYN FITZGERALD SENIOR VP, US & GLOBAL DEV 40.00 X 284735 0 63830 KRISTINA M GREGORY VP, CLINICAL INFORMATION OPERATIONS 40.00 X 232390 0 35110 LINDA LEACH VP, ADMIN. & HUMAN RESOURCES 40.00 X 219644 0 34076 EILEEN BOSCIA CONTROLLER 40.00 X 182321 0 24533 SUSAN MOST DIRECTOR, CLINICAL OPERATION 40.00 X 170040 0 33907 JENNIFER TREDWELL SENIOR DIRECTOR, MARKETING 40.00 X 148467 0 52310 3112868 0 503230 30 0 1 0 ROSEN SHINGLE CREEK 9939 UNIVERSAL BLVD ORLANDO FL 32819 CONFERENCE PRODUCTION 1461690 HEALTH RESEARCH INC ELM CARLTON STREETS BUFFALO NY 14263 RESEARCH 660856 CLINICAL CARE OPTIONS LLC 12001 SUNRISE VALLEY DRIVE SUITE 3 RESTON VA 20191 MEDICAL EDUCATION PROGRAM SERVICES 498086 BOEHRINGER INGELHEIM PHARMA 900 RIDGEBURY RD PO BOX 368 RIDGEFIELD CT 06877 RESEARCH 468417 IBM CORPORATION 275 VIGER EAST MONTREAL QUEBEC CA H2X 3R7 SOFTWARE CONSULTING 402920 5 3655000 14189586 17844586 LICENSE FEES 900099 5543248 5543248 PERMISSION FEES 900099 3881977 3881977 GUIDELINE DISTRIBUTION 900099 1956532 1956532 SUBSCRIPTIONS 900099 1360009 1360009 3078114 3078114 15819880 147091 147091 688228 688228 ADVERTISING 541800 191214 191214 191214 34690999 16508108 191214 147091 1774075 1774075 2160005 1666862 440306 52837 9452220 8438665 621344 392211 632077 551326 56528 24223 2556708 2230077 228651 97980 717274 625639 64147 27488 341412 228113 113299 68188 13300 54888 824654 708228 116426 123439 67659 55780 258287 201897 56303 87 990348 799025 191007 316 945672 945672 1386503 1152207 225208 9088 2396356 2396356 91606 91606 145991 864 145127 CATERING 389130 315735 73395 HONORARIA 311762 311762 PRINTING AND PUBLICATIO 296911 295975 936 A/V EXPENSES 282789 248465 34324 718625 531782 184606 2237 26864032 22558012 3699553 606467 25474468 33170246 15765580 15875047 4539693 3553744 2104960 1860885 178155 524928 681360 683498 2286361 1840258 402694 446103 49146910 56114451 2423407 2302392 15482578 14744264 17905985 17046656 X 25936673 33868986 5304252 5198809 31240925 39067795 49146910 56114451 7826967 -97 0 X X 0 1 X 1 0 X 14251457 16954382 16644006 17007659 17844586 82702090 14251457 16954382 16644006 17007659 17844586 82702090 6968233 75733857 567540 547109 546617 584784 835319 3081369 62096 80716 117219 93650 86428 440109 7974208 10237397 11748410 14874838 15819880 60654733 146878301 0.51560 0.50990 X SCHEDULE A - PART II SECTION B LINE 10 OTHER INCOME INCLUDES THE FOLLOWING ITEMS: GUIDELINE DISTRIBUTION $1,956,532 PERMISSION FEES 3,881,977 SUBSCRIPTION REVENUE FROM THE NCCN COMPENDIA, CHEMOTHERAPY ORDER TEMPLATES AND FLASH UDPATES 1,360,009 LICENSE FEE REVENUE FOR LICENSING OF NCCN PRODUCTS 5,543,248 REGISTRATION FEES FOR NCCN EDUCATIONAL PROGRAMS 433,668 TRENDS SURVEY FEES FOR NCCN TRENDS REPORTS 340,833 TUITION FEES FOR NCCN ACADEMY 522,597 ACCESS FEES FOR NCCN CONTENT 81,250 EXHIBIT FEES FOR EXHIBITING AT NCCN EDUCATIONAL PROGRAMS 745,500 CONSULTING REVENUE 721,129 FELLOWSHIP GRANT 233,137 TOTAL $15,819,880 0 1 0 1 0 0 1 0 0 0 0 SCHEDULE C PART II-B, LINES 1B, 1D & 1G GOP CAUCUS LETTER. AMERICAN HEALTHCARE ASSOCIATION (AHCA) LETTER. SENATOR GRASSLEY LETTER OF SUPPORT. VISIT TO SENATOR GRASSLEY'S OFFICE ON MAY 17, 2017. VISITS WITH CONGRESSMAN MEEHAN AND CONGRESSMAN FITZPATRICK ON JULY 26, 2017. NCCN SIGNED ON TO FIVE COMMENT LETTERS. 208080 49300 158780 2078281 1790958 287323 446103 34690902 -97 -97 34690999 0 34690999 26864032 0 26864032 0 26864032 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES 55715 EUROPE 0 0 PROGRAM SERVICES 20875 0 0 0 0 0 0 76590 0 76590 0 0 0 0 0 0 SCHEDULE F - PART I LINE 3(F) THE METHOD USED TO ACCOUNT FOR THE ORGANIZATION'S EXPENDITURES IS THE ACCRUAL BASIS OF ACCOUNTING. THIS IS THE SAME METHOD USED IN THE ORGANIZATION'S FINANCIAL STATEMENTS. 1 CITY OF HOPE COMP CANCER CTR 1500 E DUARTE RD DUARTE CA 91010 951683875 501(C)(3) 88735 RESEARCH DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BP320 BOSTON MA 02215 043320640 501(C)(3) 114525 RESEARCH DUKE UNIVERSITY 3100 TOWER BLVD STE 1300 DURHAM NC 27707 560532129 501(C)(3) 52700 RESEARCH GEORGETOWN UNIVERSITY 3900 RESERVOIR ROAD NW WASHINGTON DC 20007 530196603 501(C)(3) 12911 RESEARCH HEALTH RESEARCH INC ROSEWELL PARK CANCER CENTER - ELM AND CARLTON STREETS BUFFALO NY 14263 141402155 501(C)(3) 660856 RESEARCH MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131624182 501(C)(3) 332515 RESEARCH NORTHWESTERN UNIVERSITY HEALTH SYSTEM 750 N LAKE SHORE DRIVE 7TH FLOOR CHICAGO IL 60611 362167817 501(C)(3) 86596 RESEARCH THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER 1960 KENNY ROAD COLUMBUS OH 43221 316401599 501(C)(3) 89438 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA 1855 FOLSOM STREET ROOM 425 SAN FRANCISCO CA 94143 946036493 501(C)(3) 31470 RESEARCH STANFORD UNIVERSITY PO BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(C)(3) 20179 RESEARCH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE AVE UNIT 176 HOUSTON TX 77030 746001118 501(C)(3) 17690 RESEARCH UNIVERSITY OF WASHINGTON 825 EASTLAKE AVENUE SEATTLE WA 98109 916001537 115 6480 RESEARCH VANDERBILT UNIVERSITY MEDICAL CENTER DEPARTMENT OF FINANCE AT40303 ATLANTA GA 311920303 620476822 501(C)(3) 98126 RESEARCH WASHINGTON UNIVERSITY 700 ROSEDALE AVENUE ST LOUIS MO 63112 430653611 501(C)(3) 13434 RESEARCH YALE UNIVERSITY 100 CHURCH STREET SOUTH SUITE A160 NEW HAVEN CT 06520 060646973 501(C)(3) 149863 RESEARCH 15 0 PART I, LINE 2: NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) ENTERS INTO RESEARCH GRANT AGREEMENTS WITH INSTITUTIONS TO CONDUCT RESEARCH FOR INDIVIDUAL STUDY PROJECTS APPROVED BY NCCN'S SCIENTIFIC REVIEW COMMITTEES. THE SCOPE AND NATURE OF STUDIES TO BE PERFORMED BY GRANT RECIPIENTS ARE IN ACCORDANCE WITH THE APPROVED PROTOCOLS DEVELOPED BY THE PRINCIPAL INVESTIGATORS AND CONSISTENT WITH THE PROPOSALS SUBMITTED TO AND APPROVED BY THE NCCN SCIENTIFIC REVIEW COMMITTEES. PRINCIPAL INVESTIGATORS OR THEIR INSTITUTIONS MUST ATTEST THAT THEY WILL ABIDE BY THE TERMS OF NCCN RESEARCH AGREEMENTS AND THAT THE PRINCIPAL INVESTIGATORS HAVE NOT BEEN DISBARRED UNDER ANY RELEVANT STATUTES. IF AN INSTITUTION DOES NOT COMMENCE A STUDY WITHIN THE REQUIRED TIMELINE, NCCN MAY REQUEST THE INVESTIGATOR SUBMIT A CORRECTIVE ACTION PLAN FOR NCCN'S APPROVAL OR TERMINATE THE STUDY. DURING THE TERM OF THE GRANT, INSTITUTIONS REPORT TO NCCN ON A MONTHLY OR QUARTERLY BASIS THE STATUS AND PROGRESS OF THE FUNDED STUDIES. REPORTS INCLUDE AN ASSESSMENT OF TOTAL ENROLLMENT, ELIGIBILITY, AND ACCRUAL OF PATIENTS. IN CONSIDERATION FOR PERFORMANCE OF THE STUDY, NCCN DISTRIBUTES GRANT MONIES TO INSTITUTIONS WHEN CERTAIN BENCHMARKS FOR PATIENT ACCRUAL ARE MET AND THE FINAL PAYMENT IS DISBURSED UPON RECEIPT OF FINAL REPORTS AND / OR MANUSCRIPTS. INSTITUTIONS THAT DO NOT ENROLL THEIR STUDIES FULLY ARE REQUIRED TO RECONCILE STUDY EXPENSES AT TERMINATION OR COMPLETION AND RETURN UNUSED FUNDS TO NCCN WHICH ARE IN TURN RETURNED TO THE GRANTOR. X X X X X 0 0 0 0 0 0 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 682012 0 120000 0 0 0 27000 0 37210 0 866222 0 0 0 GARY WEYHMULLER CHIEF OPERATING OFFICER 394318 0 37895 0 0 0 27000 0 43210 0 502423 0 0 0 LISA G KIMBRO CHIEF FINANCIAL OFFICER 291424 0 29516 0 0 0 27000 0 41201 0 389141 0 0 0 JOAN S MCCLURE SENIOR VP, CLINICAL INFORM 290806 0 29300 0 0 0 27000 0 29843 0 376949 0 0 0 C LYN FITZGERALD SENIOR VP, US & GLOBAL DEV 258360 0 26375 0 0 0 26740 0 37090 0 348565 0 0 0 KRISTINA M GREGORY VP, CLINICAL INFORMATION OPERATIONS 211279 0 21111 0 0 0 21403 0 13707 0 267500 0 0 0 LINDA LEACH VP, ADMIN. & HUMAN RESOURCES 199644 0 20000 0 0 0 20369 0 13707 0 253720 0 0 0 EILEEN BOSCIA CONTROLLER 165742 0 16579 0 0 0 10943 0 13590 0 206854 0 0 0 SUSAN MOST DIRECTOR, CLINICAL OPERATION 157240 0 12800 0 0 0 10544 0 23363 0 203947 0 0 0 JENNIFER TREDWELL SENIOR DIRECTOR, MARKETING 143967 0 4500 0 0 0 9907 0 42403 0 200777 0 0 0 FORM 990, PART I, LINE 6, VOLUNTEERS: NCCN HAD 1,355 VOLUNTEERS COMMIT APPROXIMATELY 31,055 VOLUNTEER HOURS AS PANEL MEMBERS UPDATING EACH OF THE NCCN GUIDELINES FOR CANCER TREATMENT. FORM 990, PART VI, SECTION B, LINE 11B NCCN PROVIDES A DRAFT COPY OF THE FORM 990 TO THE FINANCE COMMITTEE OF THE BOARD OF DIRECTORS FOR ITS REVIEW AND APPROVAL PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C NCCN REQUIRES OFFICERS, DIRECTORS, AND KEY EMPLOYEES TO ANNUALLY COMPLETE A CONFLICT OF INTEREST QUESTIONNAIRE. THIS QUESTIONNAIRE SHALL BE UPDATED AS NECESSARY TO REFLECT CHANGES DURING THE COURSE OF THE YEAR. COMPLETED QUESTIONNAIRES SHALL BE AVAILABLE FOR INSPECTION BY ANY BOARD MEMBER AND MAY BE REVIEWED BY NCCN'S LEGAL COUNSEL. SENIOR NCCN STAFF REVIEW THE CONFLICT OF INTEREST FORMS ANNUALLY, PROVIDE A REPORT TO THE EXECUTIVE COMMITTEE AND TAKE CORRECTIVE ACTION IF NEEDED. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF NCCN'S CHIEF EXECUTIVE OFFICER (CEO) IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CHAIRMAN OF NCCN'S BOARD OF DIRECTORS TO CONDUCT A SALARY COMPARABILITY STUDY AND SURVEY. A SALARY COMPARABILITY STUDY WAS CONDUCTED BY AN INDEPENDENT ORGANIZATION DURING 2017. THE INFORMATION FROM THE SURVEY CONDUCTED BY THE INDEPENDENT ORGANIZATION IS FORWARDED TO NCCN'S EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. EACH YEAR, THE EXECUTIVE COMMITTEE OF NCCN'S BOARD OF DIRECTORS RECEIVES INFORMATION REGARDING THE CEO'S PAST SALARY HISTORY AS WELL AS THE CEO'S ACCOMPLISHMENTS. NCCN'S EXECUTIVE COMMITTEE SCHEDULES A CONFERENCE CALL TO REVIEW THIS INFORMATION AND TO DISCUSS RECOMMENDATIONS FOR THE CEO'S SALARY AND BONUS FOR THE UPCOMING YEAR. FORM 990, PART VI, SECTION B, LINE 15B: THE COMPENSATION OF NCCN'S CHIEF OPERATING OFFICER (COO), CHIEF FINANCIAL OFFICER (CFO), SENIOR VICE PRESIDENT OF CLINICAL INFORMATION AND PUBLICATIONS, AND SENIOR VICE PRESIDENT U.S. & GLOBAL DEVELOPMENT IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CEO OF NCCN. THE ORGANIZATION CONDUCTS A SALARY COMPARABILITY STUDY AND SURVEY FOR COMPARABLE POSITIONS IN SIMILAR ORGANIZATIONS. A SALARY COMPARABILITY STUDY WAS CONDUCTED BY AN INDEPENDENT ORGANIZATION DURING 2017. THE CEO REVIEWS THE SALARY STUDY AND SURVEY TO DETERMINE THE COMPENSATION FOR THE ABOVE KEY EMPLOYEES OF NCCN. FORM 990, PART VI, SECTION C, LINE 19 NCCN MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THE FINANCE COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT AND SELECTION OF AN INDEPENDENT ACCOUNTANT. NCCN FOUNDATION 275 COMMERCE DRIVE STE 300 FORT WASHINGTON PA 19034 271536314 FOUNDATION DE 501(C)(3) LINE 7 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 NCCN FOUNDATION L 711867 FMV NCCN FOUNDATION O 740862 FMV PART V LINE 2C SALARIES AND BENEFITS $594,805 PROFESSIONAL FEES 73,110 TRAVEL AND MEETINGS 43,781 OFFICE EXPENSE 5,148 SUPPLIES AND PRINTING 8,885 OTHER EXPENSES 5,183 MARKETING AND PUBLIC RELATIONS 8,456 TELEPHONE 1,494 TOTAL $740,862